Colombia’s PASSUS IPS Warns of Service Suspension Over EPS Debts

Media partner

POLICY & MARKETS · JULY 30, 2026 · LATIN AMERICA

Unpaid debts from Colombia’s health-insurance entities are pushing at least one provider toward a breaking point. PASSUS IPS, a Colombian healthcare provider, has publicly warned that it may suspend health services if outstanding balances owed by Entidades Promotoras de Salud (EPS) — the insurers that intermediate coverage under Colombia’s contributory and subsidised health regimes — are not settled, according to reporting by Portafolio.

The warning is significant not because provider-payer payment disputes are unusual in Colombia, but because a public threat of service suspension represents a point at which a private financial problem becomes a public-access crisis. When a provider signals it cannot continue operating on the basis of current receivables, the cost of inaction shifts from the balance sheet to patients — and, by extension, to the regulators and government bodies responsible for system solvency.

The announcement does not specify the total value of the debts alleged to be outstanding, the identity of the specific EPS entities involved, or the timeline PASSUS IPS has set before any suspension would take effect. Those details have not been publicly disclosed in the available record.

What the situation does confirm is a structural dynamic that has recurred across Colombia’s health financing architecture: providers deliver services under contractual obligation to EPS entities, but payment timelines are frequently extended beyond agreed terms, creating a liquidity gap that falls on the provider to absorb. For smaller or mid-sized institutions without the capital reserves to bridge extended receivables cycles, that gap can become existential. PASSUS IPS appears to be at that threshold, according to the Portafolio report.

The patient-access dimension is direct. A suspension of services at PASSUS IPS would disrupt care for the patients it currently serves — the scale of that population has not been disclosed in available press materials. The broader concern, however, is systemic: if EPS payment arrears are sufficiently widespread, other providers facing comparable receivables pressure may reach similar decisions, compressing the network of available care without any formal regulatory action triggering the contraction.

The principal counterargument to framing this as a structural failure is that Colombia’s health system has operated under chronic financing tension for years without producing widespread provider exits. EPS entities have historically renegotiated payment terms, and national government interventions — including the Superintendencia Nacional de Salud, Colombia’s health-system regulator — have at times stepped in to mediate or mandate payment. The question is whether those mechanisms will engage quickly enough to prevent a suspension, or whether PASSUS IPS’s warning will be treated as a negotiating posture rather than an operational threshold. The available record does not confirm whether any regulatory intervention has been initiated in this case.

The deeper signal is one of sequencing risk: Colombia’s health financing model places providers at the end of a payment chain that begins with premium collection and passes through EPS intermediaries before reaching the institutions that actually deliver care. When that chain slows, the financial stress does not distribute evenly — it concentrates at the provider level, where the capacity to absorb it is lowest.